Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea (Q34018277)

30 July 2017

title

Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea (English)

1 reference

30 July 2017

0 references

0 references

Clostridium difficile

0 references

7

Hyun Chae Jung

1 reference

30 July 2017

Ji Won Kim

1

1 reference

30 July 2017

Kook Lae Lee

2

1 reference

30 July 2017

Ji Bong Jeong

3

1 reference

30 July 2017

Byeong Gwan Kim

4

1 reference

30 July 2017

Sue Shin

5

1 reference

30 July 2017

Joo Sung Kim

6

1 reference

30 July 2017

In Sung Song

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

World Journal of Gastroenterology

30 July 2017

published in

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

28

1 reference

30 July 2017

page(s)

3573-3577

1 reference

Treatment of Clostridium difficile-associated disease

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Clostridium difficile associated infection, diarrhea and colitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

In vitro killing of nosocomial pathogens by acid and acidified nitrite

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Recurrent clostridium difficile

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Recurrent Clostridium difficile diarrhoea

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Clostridium difficile--Associated diarrhea: A review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Meta-analysis to assess risk factors for recurrent Clostridium difficile infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Risk factors for early recurrent Clostridium difficile-associated diarrhea.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Chronic septic arthritis and osteomyelitis in a prosthetic knee joint due toClostridium difficile

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909558

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients

29 October 2018

1 reference

12 December 2020

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

Clostridium difficile infection as a cause of severe sepsis

1 reference

12 December 2020

Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control

1 reference

12 December 2020

Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

1 reference

12 December 2020

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

1 reference

12 December 2020

Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster

1 reference

12 December 2020

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V16.I28.3573

1 reference

30 July 2017

1 reference

30 July 2017

1 reference